150-Year-Old Aetna Pitches Itself As A Growth Company
Few investors consider a 150-year-old company as one that has a pathway toward growth, but there are always exceptions to every rule. Barclays' Joshua Raskin maintains an Overweight rating on the 150-year old diversified healthcare company Aetna Inc (NYSE: AET) with a $162 price target. In a research report titled "Did You Know Aetna Is A Growth Company?" Raskin justified his bullish stance after attending the company's Investor Day event on Friday.
"Aetna is a growth company," the analyst wrote. "While the perception leans against that claim, Aetna did a very good job of laying out its rationale for that assertions."
Raskin continued with four simple facts to support his thesis:
Evolution Of Mix
Raskin further noted that Aetna's management was able to shift the company over the past few years to one where it is positioned today to benefit from a higher mix of revenue from growth opportunities. Of particular note, the company "has consciously pivoted" toward the government segment, and "empirical evidence shows clear out-performance" in this segment.
Raskin added that Aetna has done a "remarkable job" over the years and the company's story isn't recognized by investors as it should.
Bottom line, the analyst believes Aetna is still well positioned for continued growth in the broader managed care landscape and expect "strong returns to continue in the future."
Related Links:
Deutsche Initiates Coverage On Health Stocks As National Health Insurance Debate Rages On
In The Wake Of Failed Merger With Aetna, Humana Regains Outperform Rating From Oppenheimer
_________
Image Credit: By GK tramrunner229 - Own work, CC BY-SA 3.0, via Wikimedia Commons
Latest Ratings for AET
Apr 2017 | Deutsche Bank | Initiates Coverage On | Hold | |
Jan 2017 | Leerink Swann | Downgrades | Outperform | Market Perform |
Jan 2017 | PiperJaffray | Initiates Coverage On | Neutral |
View More Analyst Ratings for AET
View the Latest Analyst Ratings
See more from Benzinga
CyberArk Shares Likely To Trade Range Bound For Now; Imperial Downgrades
Who Needs All This Political Worry? This Pro Says Invest Outside The US
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
